These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 29283548)

  • 1. Granulocyte Colony-Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part I): Synthesis and Biodistribution Studies.
    De Crozals G; Kryza D; Sánchez GJ; Roux S; Mathé D; Taleb J; Dumontet C; Janier M; Chaix C
    Bioconjug Chem; 2018 Mar; 29(3):795-803. PubMed ID: 29283548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-Colony Stimulating Factor Nanocarriers for Stimulation of the Immune System (Part II): Dose-Dependent Biodistribution and In Vivo Antitumor Efficacy in Combination with Rituximab.
    Kryza D; De Crozals G; Mathe D; Taleb Sidi-Boumedine J; Janier M; Chaix C; Dumontet C
    Bioconjug Chem; 2018 Mar; 29(3):804-812. PubMed ID: 29283559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles.
    Su FY; Chuang EY; Lin PY; Chou YC; Chen CT; Mi FL; Wey SP; Yen TC; Lin KJ; Sung HW
    Biomaterials; 2014 Apr; 35(11):3641-9. PubMed ID: 24477192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of heparosan-granulocyte-colony stimulating factor conjugates: a natural sugar-based drug delivery system to treat neutropenia.
    Jing W; Roberts JW; Green DE; Almond A; DeAngelis PL
    Glycobiology; 2017 Nov; 27(11):1052-1061. PubMed ID: 28973394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged circulation and in vivo efficacy of recombinant human granulocyte colony-stimulating factor encapsulated in polymeric micelles.
    Harada M; Ohuchi M; Hayashi T; Kato Y
    J Control Release; 2011 Nov; 156(1):101-8. PubMed ID: 21723892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical wound healing using hemostatic gauze scaffold loaded with nanoparticles containing sustained-release granulocyte colony-stimulating factor.
    Yuan W; Liu Z
    Int J Nanomedicine; 2011; 6():3139-49. PubMed ID: 22163165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
    Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant.
    Liu T; Liu H; Fu C; Li L; Chen D; Zhang Y; Tang F
    J Colloid Interface Sci; 2013 Jun; 400():168-74. PubMed ID: 23582904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-enhancing effect of nano-DNA vaccine encoding a gene of the prME protein of Japanese encephalitis virus and BALB/c mouse granulocyte-macrophage colony-stimulating factor.
    Zhai Y; Zhou Y; Li X; Feng G
    Mol Med Rep; 2015 Jul; 12(1):199-209. PubMed ID: 25738258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
    Hattori K; Orita T; Oheda M; Tamura M; Ono M
    In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel G-CSF conjugated anionic globular dendrimer: Preparation and biological activity assessment.
    Mousavi Motlagh SS; Seyedhamzeh M; Ahangari Cohan R; Shafiee Ardestani M; Vaziri B; Azadmanesh K; Saberi S; Masoumi V
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00826. PubMed ID: 34269522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronopharmacology of granulocyte colony-stimulating factor in mice.
    Ohdo S; Arata N; Furukubo T; Yukawa E; Higuchi S; Nakano S; Ogawa N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):242-6. PubMed ID: 9536017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembling nanocomposites for protein delivery: supramolecular interactions between PEG-cholane and rh-G-CSF.
    Salmaso S; Bersani S; Mastrotto F; Tonon G; Schrepfer R; Genovese S; Caliceti P
    J Control Release; 2012 Aug; 162(1):176-84. PubMed ID: 22727711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of polymorphonuclear neutrophils (PMNs) in clearance of granulocyte colony-stimulating factor (G-CSF) in vivo and in vitro.
    Ericson SG; Gao H; Gericke GH; Lewis LD
    Exp Hematol; 1997 Dec; 25(13):1313-25. PubMed ID: 9406990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
    Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni AM
    J Clin Oncol; 1996 Feb; 14(2):628-35. PubMed ID: 8636780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose continuous subcutaneous infusion of granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics.
    Ikeda K; Tasaka T; Sasaki K; Murata M; Kitanaka A; Nagai M; Kawanishi K; Takahara J; Irino S
    Leukemia; 1994 Nov; 8(11):1838-41. PubMed ID: 7526087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.